RT Journal Article
SR Electronic
T1 Prediction of ADHD diagnosis using brief, low-cost, clinical measures: a competitive model evaluation
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.12.23.21268330
DO 10.1101/2021.12.23.21268330
A1 Mooney, Michael A.
A1 Neighbor, Christopher
A1 Karalunas, Sarah
A1 Dieckmann, Nathan F.
A1 Nikolas, Molly
A1 Nousen, Elizabeth
A1 Tipsord, Jessica
A1 Song, Xubo
A1 Nigg, Joel T.
YR 2021
UL http://medrxiv.org/content/early/2021/12/30/2021.12.23.21268330.abstract
AB Proper diagnosis of ADHD is costly, requiring in-depth evaluation via interview, multi-informant and observational assessment, and scrutiny of possible other conditions. The increasing availability of data may allow the development of machine-learning algorithms capable of accurate diagnostic predictions using low-cost measures. We report on the performance of multiple classification methods used to predict a clinician-consensus ADHD diagnosis. Classification methods ranged from fairly simple (e.g., logistic regression) to more complex (e.g., random forest), and also included a multi-stage Bayesian approach. All methods were evaluated in two large (N>1000), independent cohorts. The multi-stage Bayesian classifier provides an intuitive approach that is consistent with clinical workflows, and is able to predict ADHD diagnosis with high accuracy (>86%)—though not significantly better than other commonly used classifiers, including logistic regression. Results suggest that data from parent and teacher surveys is sufficient for high-confidence classifications in the vast majority of cases using relatively straightforward methods.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by funding from the National Institute of Mental Health (R37MH059105).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of Oregon Health & Science University gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData from both the Oregon-ADHD-1000 (collection 2857) and Michigan-ADHD-1000 (collection 3753; in progress) are being made available on the NIMH Data Archive. https://nda.nih.gov/edit_collection.html?id=2857 https://nda.nih.gov/edit_collection.html?id=3753